Yashoda Hospitals

Yashoda Hospitals is one of Hyderabad's largest and most prestigious private hospital groups, operating four independent campuses across the twin cities of Hyderabad and Secunderabad in Telangana. The group provides quaternary-level care to patients from Andhra Pradesh, Telangana, and internationally, particularly from the Gulf Cooperation Council (GCC) countries, East Africa, and other South Asian nations.

With JCI (Joint Commission International) and NABH accreditations across all its branches, Yashoda Hospitals represents the highest standards of clinical quality in the Hyderabad healthcare landscape. The combined bed capacity across four campuses — at Secunderabad, Malakpet, Somajiguda, and Hitec City — is approximately 2,756 beds, with over 646 specialist doctors and four dedicated Cancer Institutes and four Heart Institutes.

Yashoda Hospitals has established several landmark medical achievements in the Telugu-speaking states. In 2012, it performed the first lung transplantation in Andhra Pradesh and Telangana, and in 2017 it conducted the first combined heart and lung transplant in the Telugu states — a highly complex procedure requiring a large, coordinated multidisciplinary surgical team. The group treats approximately 17,000 new cancer patients per year through its four Cancer Institutes. Its oncology programme was among the first in Hyderabad to deploy RapidArc radiation technology, treating over 10,000 patients with advanced radiotherapy.

Yashoda Hospitals covers all major medical and surgical disciplines at quaternary care level. The Cardiac Sciences programme — delivered through four dedicated Heart Institutes — encompasses interventional cardiology (coronary angiography, angioplasty, structural heart interventions), cardiac electrophysiology, cardiac surgery (CABG, valve repair and replacement), and heart and lung transplantation.

The Neurosciences department provides comprehensive neurology and neurosurgery services including stroke management, epilepsy surgery, brain tumour resection, spinal surgery, and deep brain stimulation. Four Cancer Institutes deliver multi-modal oncology including medical oncology, surgical oncology, radiation therapy (with RapidArc and IGRT), bone marrow transplantation, and targeted and immunotherapy programmes.

Organ transplantation — kidney, liver, heart, and lung — is a marquee capability of the Yashoda group. Nephrology and dialysis services are available across all campuses. Gastroenterology, hepatology, and bariatric surgery cater to the growing burden of metabolic and digestive diseases. Orthopaedics and joint replacement, pulmonology, gynaecology, obstetrics, paediatric intensive care, neonatology, urology, and endocrinology complete the hospital's comprehensive specialty portfolio.

Yashoda Hospitals' four campuses collectively provide approximately 2,756 beds, four dedicated Cancer Institutes, four Heart Institutes, and advanced diagnostic and procedural infrastructure across Hyderabad and Secunderabad. Each campus is equipped with modern cardiac catheterisation laboratories, advanced imaging (3T MRI, 64-slice CT, PET-CT), robotic surgical systems, bone marrow transplant units, and neonatal ICUs.

The radiation oncology infrastructure includes RapidArc technology for image-guided, intensity-modulated radiotherapy — enabling precise tumour targeting with sparing of surrounding healthy tissue. All campuses maintain 24-hour emergency and trauma departments, blood banks, NABL-accredited laboratories, and comprehensive pharmacy services. Physiotherapy and rehabilitation centres support post-surgical and neurological recovery. The Hitec City campus caters particularly to IT sector employees and their families, offering occupational health services and executive health check packages. Bone marrow transplant units at the oncology centres manage autologous and allogeneic BMT for blood cancers.

Yashoda Hospitals has well-established international patient services, regularly treating patients from the Gulf Cooperation Council (GCC) countries — particularly Oman, UAE, Kuwait, and Saudi Arabia — as well as from East Africa, South-East Asia, and other countries with Telangana diaspora communities.

The international patient coordination team provides medical visa invitation letters, pre-arrival telemedicine consultations, treatment cost estimates across all specialties, airport pickup, and accommodation coordination near each campus. Translation and interpretation support is available in Telugu, Hindi, English, and Arabic. Hyderabad's Rajiv Gandhi International Airport offers direct flights to Dubai, Abu Dhabi, Doha, Muscat, Kuala Lumpur, Singapore, and multiple European cities, making it highly accessible for Gulf and international patients. All Yashoda campuses are NABH and NABL accredited, and the group holds JCI accreditation — international quality certifications that give overseas patients confidence in the hospital's safety and quality standards.

Yashoda Hospitals holds JCI (Joint Commission International) accreditation — the globally recognised gold standard for hospital quality and patient safety — across its campuses. All branches are also NABH (National Accreditation Board for Hospitals and Healthcare Providers) and NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited, a triple accreditation that represents the highest level of quality assurance in Indian healthcare.

The group's clinical governance framework encompasses regular multidisciplinary audits, infection control monitoring, outcome tracking, and continuous medical education to keep clinical teams updated with international best practices. NABH accreditation confirms standardised processes in patient admission, care delivery, medication management, surgical safety, infection control, and discharge planning across all four campuses. The JCI accreditation further validates compliance with international patient safety goals and clinical quality metrics. Yashoda's milestone transplant achievements — India's first lung transplant in the Telugu states (2012) and the first combined heart-lung transplant (2017) — are recognised by the national medical community as benchmarks of surgical excellence.